NEW YORK (GenomeWeb) - WuXi NextCode said today that it has closed a $75 million Series B financing in which several of the company's existing investors and partners participated.

Temasek and Yunfeng Capital co-led the financing. Other investors include Amgen Ventures and 3W Partners. Temasek is a Singapore-based investment firm, while Yunfeng is a private equity firm founded by Alibaba Group Holding's Jack Ma.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.